lambda-cyhalotryna - søkeresultat

Den europeiske union - norsk - EMA (European Medicines Agency)

victrelis

merck sharp dohme ltd - boceprevir - hepatitt c, kronisk - antivirale midler til systemisk bruk - victrelis er indisert for behandling av kronisk hepatitt-c (chc) genotype-1 smitte, i kombinasjon med peginterferon alfa og ribavirin hos voksne pasienter med kompensert leversykdom som tidligere ubehandlet eller som har mislyktes tidligere terapi.

Den europeiske union - norsk - EMA (European Medicines Agency)

evusheld

astrazeneca ab - tixagevimab, cilgavimab - covid-19 virus infection - prevention of covid-19.

Den europeiske union - norsk - EMA (European Medicines Agency)

veklury

gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.

Den europeiske union - norsk - EMA (European Medicines Agency)

regkirona

celltrion healthcare hungary kft. - regdanvimab - covid-19 virus infection - immune sera og immunglobuliner, - regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (covid-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.

Den europeiske union - norsk - EMA (European Medicines Agency)

xevudy

glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - immune sera og immunglobuliner, - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.